Formation of Toxic Fibrils of Alzheimer's Amyloid β-Protein-(1-40) by Monosialoganglioside GM1, a Neuronal Membrane Component

Journal of Molecular Biology

Volumn 371, Issue 2, 2007, Pages 481-489

  Okada, Takuma ^a   Wakabayashi, Masaki ^a   Ikeda, Keisuke ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; amyloid protein; monosialoganglioside GM1; polymorphism; toxicity

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN[1-40]; GANGLIOSIDE GM1; GANGLIOSIDE GT1B; GLYCOLIPID; MONOSIALOGANGLIOSIDE; NERVE GROWTH FACTOR; PHOSPHATE BUFFERED SALINE; THIOFLAVINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL STRAIN; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DISEASE EXACERBATION; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; NERVE CELL LESION; NERVE CELL MEMBRANE; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RAT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 34447255463     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.05.069     Document Type: Article

References (50)

1. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
2. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
3. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
4. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95 (1998) 6448-6453
5. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24 (2004) 10191-10200
6. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M. P., Finch C.E., et al. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100 (2003) 10417-10422
7. Chromy B.A., Nowak R.J., Lambert M.P., Viola K. L., Chang L., Velasco P.T., et al. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
8. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
9. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
10. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
11. Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N., and Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl Acad. Sci. USA 100 (2003) 6370-6375
12. Barghorn S., Nimmrich V., Striebinger A., Krantz C., Keller P., Janson B., et al. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95 (2005) 834-847
13. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
14. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
15. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277 (2002) 32046-32053
16. Davis-Salinas J., and Van Nostrand W.E. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270 (1995) 20887-20890
17. Grace E.A., Rabiner C.A., and Busciglio J. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114 (2002) 265-273
18. Jana A., and Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J. Biol. Chem. 279 (2004) 51451-51459
19. Lorenzo A., and Yankner B.A. Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann. N Y Acad. Sci. 777 (1996) 89-95
20. Pallitto M.M., and Murphy R.M. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 81 (2001) 1805-1822
21. Pillot T., Drouet B., Queillé S., Labeur C., Vandekerchkhove J., Rosseneu M., et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73 (1999) 1626-1634
22. Tamagno E., Bardini P., Guglielmotto M., Danni O., and Tabaton M. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41 (2006) 202-212
23. Tsai J., Grutzendler J., Duff K., and Gan W.B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neurosci. 7 (2004) 1181-1183
24. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307 (2005) 262-265
25. Blennow K., Davidsson P., Wallin A., Fredman P., Gottfries C.G., Karlsson I., et al. Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'. Arch. Neurol. 48 (1991) 1032-1035
26. Formisano S., Johnson M.L., Lee G., Aloj S.M., and Edelhoch H. Critical micelle concentrations of gangliosides. Biochemistry 18 (1979) 1119-1124
27. Yanagisawa, K. (2007). Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta. In the press.
28. Hasegawa K., Yamaguchi I., Omata S., Gejyo F., and Naiki H. Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 38 (1999) 15514-15521
29. Carrer D.C., and Maggio B. Transduction to self-assembly of molecular geometry and local interactions in mixtures of ceramides and ganglioside GM1. Biochim. Biophys. Acta 1514 (2001) 87-99
30. DeMattos R.B., O'Dell M.A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 99 (2002) 10843-10848
31. Bush A.I., Pettingell W.H., Multhaup G., d Paradis M., Vonsattel J.P., Gusella J.F., et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265 (1994) 1464-1467
32. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nature Med. 1 (1995) 1062-1066
33. Hayashi H., Kimura N., Yamaguchi H., Hasegawa K., Yokoseki T., Shibata M., et al. A seed for Alzheimer amyloid in the brain. J. Neurosci. 24 (2004) 4894-4902
34. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41 (2002) 7385-7390
35. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
36. van Meer G. Cell biology. The different hues of lipid rafts. Science 296 (2002) 855-857
37. Zha Q., Ruan Y., Hartmann T., Beyreuther K., and Zhang D. GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol. Psychiatry 9 (2004) 946-952
38. Grimm M.O., Grimm H.S., Pätzold A.J., Zinser E. G., Halonen R., Duering M., et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nature Cell Biol. 7 (2005) 1118-1123
39. Mattson M.P., Cutler R.G., and Jo D.G. Alzheimer peptides perturb lipid-regulating enzymes. Nature Cell Biol. 7 (2005) 1045-1047
40. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl Acad. Sci. USA 101 (2004) 2070-2075
41. Gylys K.H., Fein J.A., Yang F., Miller C.A., and Cole G.M. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex. Neurobiol. Aging 28 (2007) 8-17
42. Kakio A., Nishimoto S.I., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276 (2001) 24985-24990
43. Yamamoto N., Hasegawa K., Matsuzaki K., Naiki H., and Yanagisawa K. Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein. J. Neurochem. 90 (2004) 62-69
44. Johansson A.S., Garlind A., Berglind-Dehlin F., Karlsson G., Edwards K., Gellerfors P., et al. Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro. FEBS J. 274 (2007) 990-1000
45. Wakabayashi M., Okada T., Kozutsumi Y., and Matsuzaki K. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem. Biophys. Res. Commun. 328 (2005) 1019-1023
46. Yamamoto N., Matsubara E., Maeda S., Minagawa H., Takashima A., Maruyama W., et al. A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation. J. Biol. Chem. 282 (2007) 2646-2655
47. Svennerholm L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24 (1957) 604-611
48. Naiki H., and Gejyo F. Kinetic analysis of amyloid fibril formation. Methods. Enzymol. 309 (1999) 305-318
49. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
50. Päiviö A., Jarvet J., Gräslund A., Lannfelt L., and Westlind-Danielsson A. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers. J. Mol. Biol. 339 (2004) 145-159